Immunologic considerations before and after vasovasostomy

E. F. Fuchs; N. J. Alexander

doi:10.1016/S0015-0282(16)47362-0

Immunologic considerations before and after vasovasostomy

E. F. Fuchs, N. J. Alexander

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Abstract

A prospective study has been completed to determine the incidence and significance of antisperm antibodies in 160 men undergoing vasovasostomy to relieve obstruction of the vas deferens due to vasectomy. Preoperatively, serum sperm-agglutinating antibody (SSAA), serum sperm-immunobilizing antibody (SSIA), and seminal plasma sperm-agglutinating antibody (SPSAA) were found in 63%, 37%, and 3%, respectively. When they were postoperatively studied, 92 of the same men demonstrated no significant change in the incidence or the absolute level of SSAA or SSIA. The SPSAA was found in 7% of 120 men preoperatively; however, 16% of 51 men studied postoperatively exhibited SPSAA. Significant differences in pregnancy rates have been documented between the spouses of men with detectable levels of agglutinating and immobilizing antibody and the spouses of men with no evidence of antibody formation.

Original language	English (US)
Pages (from-to)	497-499
Number of pages	3
Journal	Fertility and sterility
Volume	40
Issue number	4
DOIs	https://doi.org/10.1016/S0015-0282(16)47362-0
State	Published - 1983
Externally published	Yes

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/S0015-0282(16)47362-0

Cite this

@article{c93f8e413cbc46caaa12640f533aa502,

title = "Immunologic considerations before and after vasovasostomy",

abstract = "A prospective study has been completed to determine the incidence and significance of antisperm antibodies in 160 men undergoing vasovasostomy to relieve obstruction of the vas deferens due to vasectomy. Preoperatively, serum sperm-agglutinating antibody (SSAA), serum sperm-immunobilizing antibody (SSIA), and seminal plasma sperm-agglutinating antibody (SPSAA) were found in 63%, 37%, and 3%, respectively. When they were postoperatively studied, 92 of the same men demonstrated no significant change in the incidence or the absolute level of SSAA or SSIA. The SPSAA was found in 7% of 120 men preoperatively; however, 16% of 51 men studied postoperatively exhibited SPSAA. Significant differences in pregnancy rates have been documented between the spouses of men with detectable levels of agglutinating and immobilizing antibody and the spouses of men with no evidence of antibody formation.",

author = "Fuchs, {E. F.} and Alexander, {N. J.}",

year = "1983",

doi = "10.1016/S0015-0282(16)47362-0",

language = "English (US)",

volume = "40",

pages = "497--499",

journal = "Fertility and sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Immunologic considerations before and after vasovasostomy

AU - Fuchs, E. F.

AU - Alexander, N. J.

PY - 1983

Y1 - 1983

N2 - A prospective study has been completed to determine the incidence and significance of antisperm antibodies in 160 men undergoing vasovasostomy to relieve obstruction of the vas deferens due to vasectomy. Preoperatively, serum sperm-agglutinating antibody (SSAA), serum sperm-immunobilizing antibody (SSIA), and seminal plasma sperm-agglutinating antibody (SPSAA) were found in 63%, 37%, and 3%, respectively. When they were postoperatively studied, 92 of the same men demonstrated no significant change in the incidence or the absolute level of SSAA or SSIA. The SPSAA was found in 7% of 120 men preoperatively; however, 16% of 51 men studied postoperatively exhibited SPSAA. Significant differences in pregnancy rates have been documented between the spouses of men with detectable levels of agglutinating and immobilizing antibody and the spouses of men with no evidence of antibody formation.

AB - A prospective study has been completed to determine the incidence and significance of antisperm antibodies in 160 men undergoing vasovasostomy to relieve obstruction of the vas deferens due to vasectomy. Preoperatively, serum sperm-agglutinating antibody (SSAA), serum sperm-immunobilizing antibody (SSIA), and seminal plasma sperm-agglutinating antibody (SPSAA) were found in 63%, 37%, and 3%, respectively. When they were postoperatively studied, 92 of the same men demonstrated no significant change in the incidence or the absolute level of SSAA or SSIA. The SPSAA was found in 7% of 120 men preoperatively; however, 16% of 51 men studied postoperatively exhibited SPSAA. Significant differences in pregnancy rates have been documented between the spouses of men with detectable levels of agglutinating and immobilizing antibody and the spouses of men with no evidence of antibody formation.

UR - http://www.scopus.com/inward/record.url?scp=0021039252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021039252&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(16)47362-0

DO - 10.1016/S0015-0282(16)47362-0

M3 - Article

C2 - 6617911

AN - SCOPUS:0021039252

SN - 0015-0282

VL - 40

SP - 497

EP - 499

JO - Fertility and sterility

JF - Fertility and sterility

IS - 4

ER -

Immunologic considerations before and after vasovasostomy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this